Debate: Should Biologics Be Used for Milder Cases of Psoriasis?
The remarkable efficacy of biologics for moderate-to-severe psoriasis has led some to ask if biologics should be used for milder
Read more
The remarkable efficacy of biologics for moderate-to-severe psoriasis has led some to ask if biologics should be used for milder
Read more(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody
Read moreMarine algae are relatively common raw sources for cosmeceutical products.1 The photoprotective compounds identified among marine algae range from mycosporinelike
Read moreThe number of Americans donating to crowdfunding campaigns for medical bills during 2020 held steady relative to previous years, despite
Read moreNEW YORK (Reuters Health) – The incidence of scleritis has fallen by about a third in the United Kingdom over
Read moreOlder patients recently diagnosed with dementia are at a significantly increased risk for suicide compared to their peers without dementia.
Read moreDr Kenneth Brian Gordon Several surprising recent insights into the pathophysiology of psoriasis may eventually lead to superior treatment strategies
Read moreCombining the tyrosine kinase inhibitor saracatinib with docetaxel does not benefit patients with metastatic, castration-resistant prostate cancer (mCRPC), according to
Read more